Phase III Vitiligo Study
Brief description of study
The research study is being conducted to look at the efficacy of SCENESSE® (also known as afamelanotide) combined with narrow-band ultraviolet B (NB-UVB) light in participants with nonsegmental vitiligo. Procedures: vital signs, physical examination, medical history, blood and urine tests, past and current medications, full body photography, NB-UVB light treatment, study medication implant administration. subject questionnaires and skin assessments.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
